ETrade Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
ETrade Capital Management's GILD Position: Q3 2020 in Review
ETrade Capital Management increased its Gilead Sciences (GILD) stake by 42% in Q3 2020, buying an estimated $1.18M and bringing the position to 58,075 shares worth $3.67M. The position accounts for 0.07% of the portfolio, ranked #146.
ETrade Capital Management first reported a position in GILD in Q2 2013 and has held it in 30 quarters since. The position peaked at $6.49M in Q1 2020. 1,539 funds tracked by Wall St. Rank hold GILD as of Q3 2020.
- ETrade Capital Management held 58,075 shares of Gilead Sciences worth $3.67M as of Q3 2020.
- ETrade Capital Management bought 17,064 Gilead Sciences shares in Q3 2020, an estimated $1.18M.
- Gilead Sciences made up 0.07% of ETrade Capital Management's portfolio in Q3 2020, its #146 holding.
- ETrade Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 30 quarters since.
- ETrade Capital Management's Gilead Sciences position peaked at $6.49M in Q1 2020.
- 1,539 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.
Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.